Physician profile
Gerald So
NPI 1235294695
$4,860.83
in general payments reported to CMS, 2019-2025
48 companies · $744 in 2025
The $744 reported for 2025 was more than what a typical Neurology With Special Qualifications In Child Neurology provider received nationally (typical 2025 total: $275).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $942 · 2020: $665 · 2021: $727 · 2022: $546 · 2023: $461 · 2024: $775 · 2025: $744.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,947 · Education: $33.44.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,946.96 |
| Education | $33.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $382.84 | 2019-2025 | Qelbree |
| Ucb, INC. | $366.68 | 2019-2024 | Fintepla, Briviact |
| Livanova USA, INC. | $325.73 | 2020-2025 | Vns Therapy Sentiva Model 1000 Generator |
| Neurelis, INC. | $305.89 | 2020-2025 | Valtoco |
| Sunovion Pharmaceuticals INC. | $303.93 | 2019-2022 | |
| Eisai INC. | $270.03 | 2019-2023 | |
| Corium, LLC | $221.08 | 2022-2025 | Azstarys |
| Greenwich Biosciences, INC. | $218.92 | 2019-2021 | |
| Jazz Pharmaceuticals INC. | $212.29 | 2022-2025 | |
| Immedica Pharma US, INC. | $191.16 | 2022-2024 | |
| Ironshore Pharmaceuticals INC. | $189.31 | 2019-2022 | |
| Tris Pharma INC | $139.23 | 2019-2025 | Dyanavel Xr, Onyda Xr |
| Catalyst Pharmaceuticals, INC. | $139.13 | 2023-2025 | Fycompa |
| Aquestive Therapeutics, INC. | $137.24 | 2019-2024 | |
| Sk Life Science, INC. | $124.14 | 2020-2025 |
Show all 48 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gerald So listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.